These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2429500

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Concentration gradient of CSF monoamine metabolites in children and adolescents.
    Kruesi MJ, Swedo SE, Hamburger SD, Potter WZ, Rapoport JL.
    Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
    Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA.
    J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
    [Abstract] [Full Text] [Related]

  • 25. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN.
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [Abstract] [Full Text] [Related]

  • 26. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC, Wode-Helgodt B.
    Arch Gen Psychiatry; 1980 Oct 12; 37(10):1113-6. PubMed ID: 6158928
    [Abstract] [Full Text] [Related]

  • 29. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD, Geracioti TD, Altemus M, Kling MA.
    Biol Psychiatry; 1980 Oct 12; 33(8-9):636-41. PubMed ID: 7687151
    [Abstract] [Full Text] [Related]

  • 30. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ, Logue M, Growdon JH.
    Arch Neurol; 1985 May 12; 42(5):489-92. PubMed ID: 2581531
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B, Nyberg S, Toresson G, Brodin E, Bertilsson L.
    Acta Psychiatr Scand; 1989 Jun 12; 79(6):586-96. PubMed ID: 2475012
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
    Alfredsson G, Wiesel FA, Tylec A.
    Biol Psychiatry; 1988 Apr 01; 23(7):689-97. PubMed ID: 2453224
    [Abstract] [Full Text] [Related]

  • 35. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
    Jolkkonen J, Helkala EL, Kutvonen R, Lehtinen M, Riekkinen PJ.
    Psychoneuroendocrinology; 1989 Apr 01; 14(1-2):89-95. PubMed ID: 2471986
    [Abstract] [Full Text] [Related]

  • 36. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D, Pullar IA, Mawdsley C, Kinloch N, Yates CM.
    J Neurol Neurosurg Psychiatry; 1977 Aug 01; 40(8):741-5. PubMed ID: 925693
    [Abstract] [Full Text] [Related]

  • 37. Monoamine neurotransmitter interactions and the prediction of antidepressant response.
    Hsiao JK, Agren H, Bartko JJ, Rudorfer MV, Linnoila M, Potter WZ.
    Arch Gen Psychiatry; 1987 Dec 01; 44(12):1078-83. PubMed ID: 2446588
    [Abstract] [Full Text] [Related]

  • 38. Study on monoamine metabolite contents of cerebrospinal fluid in patients with neurodegenerative diseases.
    Ichikawa N.
    Tohoku J Exp Med; 1986 Dec 01; 150(4):435-46. PubMed ID: 2436350
    [Abstract] [Full Text] [Related]

  • 39. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB, Starkstein SE, Votypka V, Parikh RM, Price TR, Robinson RG.
    J Neuropsychiatry Clin Neurosci; 1992 Dec 01; 4(4):440-2. PubMed ID: 1384852
    [Abstract] [Full Text] [Related]

  • 40. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
    Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A.
    Alzheimer Dis Assoc Disord; 1989 Dec 01; 3(3):148-56. PubMed ID: 2477044
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.